Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ovarian cancer genetics under the microscope: no treatment, just knowledge

NCT ID NCT04027868

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 1,500 women with advanced ovarian, peritoneal, or fallopian tube cancer to see how genetic changes in their tumors relate to how the disease progresses. Researchers collected tumor samples and medical data to find links between DNA abnormalities and outcomes like how long patients stayed cancer-free. The goal was to gather information, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,500 people

The number who actually took part.

Started

Dec 2019

Finished

Nov 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with ovarian and/or primitive peritoneal and/or fallopian tubes carcinoma, histologically confirmed, with an advanced stage at diagnosis (stage III to IV FIGO 2014)

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient older than 18 years. * Patient with ovarian and/or primitive peritoneal and/or fallopian tubes carcinoma, histologically confirmed, with an advanced stage at diagnosis (stage III to IV FIGO 2014) * Patient in first line therapy * Available tumor sample fixed in formalin and included in paraffin (FFPE): * in pre-chemotherapy, insofar as possible * having a sufficient tumor surface, with a final cellularity of at least 20% * Identification of a molecular genetics' cancer platform participant in GREAT and an onco-geneticists team working with the investigator team * Patient consenting her data to be collected and submitted through an automated processing * Patient beneficiary from the French social security Exclusion Criteria: * Patient with a mucinous ovarian carcinoma * Patient pregnant or breastfeeding * Patient under legal protection (guardianship or court order) or unable to consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Epithelial ovarian cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • APHM - Hôpital de la Timone

    Marseille, France

  • CH Alpes Léman

    Contamine-sur-Arve, France

  • CH Annecy Genevois

    Pringy, France

  • CH Arras

    Arras, France

  • CH Auxerre

    Auxerre, France

  • CH Broussais

    St-Malo, France

  • CH Carcassonne

    Carcassonne, France

  • CH Chalon sur Saone

    Chalon-sur-Saône, France

  • CH Cholet

    Cholet, France

  • CH Côte Basque

    Bayonne, France

  • CH Jean Bernard

    Valenciennes, France

  • CH Metropole Savoie

    Chambéry, France

  • CH Pau

    Pau, France

  • CH Perpignan

    Perpignan, France

  • CH René Dubos

    Pontoise, France

  • CH Sens

    Sens, France

  • CH de Blois

    Blois, France

  • CH de Cahors

    Cahors, France

  • CH de Lens

    Lens, France

  • CH de Montelimar

    Montélimar, France

  • CHI Creteil

    Créteil, France

  • CHPC - Hôpital Louis Pasteur

    Cherbourg, France

  • CHR Metz-Thionville / Hôpital de Mercy

    Thionville, 45001, France

  • CHR Orléans

    Orléans, France

  • CHRU Jean Minjoz

    Besançon, France

  • CHRU de Montpellier - Hôpital Saint-Eloi

    Montpellier, France

  • CHU Amiens

    Amiens, France

  • CHU Bicêtre

    Le Kremlin-Bicêtre, France

  • CHU Brest

    Brest, France

  • CHU Bretonneau

    Tours, France

  • CHU Dijon

    Dijon, France

  • CHU Grenoble Alpes - Site Nord (La Tronche)

    La Tronche, France

  • CHU Saint-Etienne - Pôle de Cancérologie

    Saint-Priest-en-Jarez, France

  • CHU de Bordeaux - Hôpital Pellegrin

    Bordeaux, France

  • CHU de Limoges - Hôpital Dupuytren

    Limoges, 87042, France

  • Centre Antoine Lacassagne

    Nice, 06000, France

  • Centre Azuréen de Cancérologie

    Mougins, 06250, France

  • Centre CARIO-HPCA

    Plérin, France

  • Centre Catalan d'Oncologie

    Perpignan, France

  • Centre Eugène Marquis

    Rennes, France

  • Centre François Baclesse

    Caen, France

  • Centre Frédéric Joliot

    Rouen, France

  • Centre Georges François Leclerc

    Dijon, France

  • Centre Henri Becquerel

    Rouen, 76000, France

  • Centre Hospitalier Départemental de Vendée

    La Roche-sur-Yon, 85925, France

  • Centre Hospitalier Fleyriat - BOURG-EN-BRESSE

    Bourg-en-Bresse, France

  • Centre Hospitalier Général d'Aix-en-Provence

    Aix-en-Provence, France

  • Centre Hospitalier Intercommunal de Fréjus Saint Raphael

    Fréjus, 83600, France

  • Centre Hospitalier Layné

    Mont-de-Marsan, 40024, France

  • Centre Hospitalier Marne-la-Vallée

    Jossigny, France

  • Centre Hospitalier Privé Saint Grégoire

    Saint-Grégoire, France

  • Centre Hospitalier Sud Francilien (Site Gilles de Corbeil)

    Corbeil-Essonnes, 91106, France

  • Centre Hospitalier Yves Le Foll

    Saint-Brieuc, France

  • Centre Hospitalier de Beauvais

    Beauvais, 60021, France

  • Centre Hospitalier de Chateauroux

    Châteauroux, 36000, France

  • Centre Hospitalier de Troyes

    Troyes, France

  • Centre Hospitalier du Mans

    Le Mans, France

  • Centre Jean Perrin

    Clermont-Ferrand, France

  • Centre Léon Bérard

    Lyon, France

  • Centre Maurice Tubiana

    Caen, France

  • Centre Médicale Sainte Feyre Alfred Leune

    Sainte-Feyre, 23000, France

  • Centre d'Oncologie et de Radiothérapie 37

    Chambray-lès-Tours, France

  • Centre de Cancérologe du Grand Montpellier

    Montpellier, France

  • Centre de Radiothérapie et d'Oncologie de Moyenne Garonne (CROMG)

    Agen, 47000, France

  • Clinique Belharra

    Bayonne, 64100, France

  • Clinique Charcot

    Sainte-Foy-lès-Lyon, France

  • Clinique Francheville

    Périgueux, France

  • Clinique Hartmann

    Neuilly-sur-Seine, France

  • Clinique Mathilde

    Rouen, 76100, France

  • Clinique Mutualiste de l'Estuaire

    Saint-Nazaire, France

  • Clinique Pasteur - Groupe Oncorad Garonne

    Toulouse, France

  • Clinique Pasteur - Oncosud

    Toulouse, France

  • Clinique Tivoli

    Bordeaux, France

  • Clinique Victor PAUCHET

    Amiens, France

  • Clinique de Flandre

    Coudekerque-Branche, France

  • Clinique de l'infirmerie Protestante

    Lyon, 69300, France

  • Clinique de la Croix du Sud

    Quint-Fonsegrives, France

  • Clinique de la Sauvegarde

    Lyon, France

  • Clinique des Cèdres

    Cornebarrieu, 31700, France

  • Clinique des Dentellières

    Valenciennes, France

  • Clinique du Mousseau (CMCO) - Ramsay Santé

    Évry, 91000, France

  • GH Mutualiste de Grenoble

    Grenoble, France

  • GH Saint Joseph

    Paris, France

  • Groupe Hospitalier Bretagne Sud - Hôpital du Scorff

    Lorient, France

  • Groupe Hospitalier Diaconesses - Croix Saint-Simon

    Paris, France

  • Groupe Hospitalier public du Sud de l'Oise (GHPSO)

    Creil, France

  • Gustave Roussy

    Villejuif, France

  • HCL - Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69006, France

  • HCL - Hôpital de la Croix Rousse

    Lyon, 60004, France

  • HEGP

    Paris, France

  • HIA Begin

    Saint-Mandé, France

  • Hôpital André Mignot

    Le Chesnay, France

  • Hôpital Antoine Béclère

    Clamart, France

  • Hôpital Avicenne

    Bobigny, 93009, France

  • Hôpital Bichat

    Paris, France

  • Hôpital Cochin

    Paris, France

  • Hôpital Femme Mère Enfant

    Bron, 89500, France

  • Hôpital Foch

    Suresnes, France

  • Hôpital Général de Castres

    Castres, France

  • Hôpital Lariboisière

    Paris, France

  • Hôpital Nord

    Marseille, France

  • Hôpital Nord Franche Comté

    Montbéliard, France

  • Hôpital Privé Drôme Ardèche - Clinique Pasteur

    Guilherand-Granges, 07500, France

  • Hôpital Privé Jean Mermoz

    Lyon, France

  • Hôpital Privé d'Aix en Provence

    Aix-en-Provence, 13080, France

  • Hôpital Privé d'Antony - Ramsay Santé

    Antony, 92160, France

  • Hôpital Privé de La Loire Saint-Etienne

    Saint-Etienne, 42100, France

  • Hôpital Privé de l'Estuaire

    Le Havre, 76600, France

  • Hôpital Privé du Confluent

    Nantes, France

  • Hôpital d'Instruction des Armées Saint-Anne

    Toulon, 83800, France

  • Hôpital de la Milétrie

    Poitiers, France

  • Hôpital de la Pitié Salpétrière

    Paris, 75000, France

  • Hôpitaux Drôme Nord - Centre Hospitalier Romans

    Romans-sur-Isère, 26100, France

  • Hôpitaux du Léman

    Thonon-les-Bains, France

  • ICANS - Institut de cancérologie Strasbourg Europe

    Strasbourg, 67037, France

  • ICM - Val d'Aurelle

    Montpellier, France

  • Institut Bergonié

    Bordeaux, France

  • Institut Claudius Regaud

    Toulouse, France

  • Institut Curie

    Paris, France

  • Institut Curie - Site Saint Cloud

    Saint-Cloud, 92210, France

  • Institut Hospitalier Franco-Britannique

    Levallois-Perret, France

  • Institut Mutualiste Montsouris

    Paris, France

  • Institut Paoli Calmettes

    Marseille, France

  • Institut Sainte Catherine

    Avignon, France

  • Institut de Cancérologie Paris Nord

    Sarcelles, France

  • Institut de Cancérologie de Bourgogne - GRReCC

    Dijon, France

  • Institut de Cancérologie de Lorraine (ICL) - Centre Alexis Vautrin

    Vandœuvre-lès-Nancy, France

  • Institut de Cancérologie de l'Ouest - ICO

    Angers, France

  • Institut de Cancérologie de l'Ouest - ICO

    Saint-Herblain, France

  • Institut de Cancérologie du Gard

    Nîmes, France

  • Institut de Cancérologie du Gard - ONCOGARD

    Nîmes, 30029, France

  • Les Hôpitaux de Chartres

    Le Coudray, France

  • Medipole de Savoie

    Challes-les-Eaux, France

  • Oracle - Centre d'Oncologie de Gentilly

    Nancy, France

  • Polyclinique Bordeaux Nord

    Bordeaux, France

  • Polyclinique de Limoges - Clinique Chenieux

    Limoges, 87039, France

  • Reims Icone

    Bezannes, 51100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.